Search Result "Kat3 coactivator."
Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage
Journal: Current Molecular Pharmacology
Volume: 12 Issue: 3 Year: 2019 Page: 167-183
Author(s): Keane K.Y. Lai,Cu Nguyen,Kyung-Soon Lee,Albert Lee,David P. Lin,Jia-Ling Teo,Michael Kahn
Differential Kat3 Coactivator Usage Regulates Brain Metabolism and NeuronalDifferentiation
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-9
Author(s):
Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency
Journal: Current Molecular Pharmacology
Volume: 9 Issue: 3 Year: 2016 Page: 272-279
Author(s): Yusuke Higuchi, Cu Nguyen, Shin-Ya Yasuda, Michael McMillan, Kouichi Hasegawa, Michael Kahn
Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription
Journal: Current Molecular Pharmacology
Volume: 6 Issue: 3 Year: 2013 Page: 204-210
Author(s): Aiko Kida,Michael Kahn
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5051-5064
Author(s): Luis M. Valor, Jose Viosca, Jose P. Lopez-Atalaya, Angel Barco
E7386 is not a Specific CBP/β-Catenin Antagonist
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-10
Author(s):
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid DeleteriousROS by Suppressing Mitochondrial Complex I
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-19
Author(s): Rafael J. Argüello
Wnt Signaling in Breast Cancer Oncogenesis, Development and Progression
Ebook: Advances in Cancer Signal Transduction and Therapy
Volume: 1 Year: 2020
Author(s): Norman Fultang,Bela Peethambaran
Doi: 10.2174/9789811458118120010003